{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:38:33Z","timestamp":1794969513981,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903602"],"award-info":[{"award-number":["81903602"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pressure overload-induced pathological cardiac hypertrophy is an independent predecessor of heart failure (HF), which remains the leading cause of worldwide mortality. However, current evidence on the molecular determinants of pathological cardiac hypertrophy is still inadequacy. This study aims to elucidate the role and mechanisms of Poly (ADP-ribose) polymerases 16 (PARP16) in the pathogenesis of pathological cardiac hypertrophy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Gain and loss of function approaches were used to demonstrate the effects of genetic overexpression or deletion of PARP16 on cardiomyocyte hypertrophic growth in vitro. Ablation of PARP16 by transducing the myocardium with serotype 9 adeno-associated virus (AAV9)-encoding PARP16 shRNA were then subjected to transverse aortic construction (TAC) to investigate the effect of PARP16 on pathological cardiac hypertrophy in vivo. Co-immunoprecipitation (IP) and western blot assay were used to detect the mechanisms of PARP16 in regulating cardiac hypertrophic development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PARP16 deficiency rescued cardiac dysfunction and ameliorated TAC-induced cardiac hypertrophy and fibrosis in vivo, as well as phenylephrine (PE)-induced cardiomyocyte hypertrophic responses in vitro. Whereas overexpression of PARP16 exacerbated hypertrophic responses including the augmented cardiomyocyte surface area and upregulation of the fetal gene expressions. Mechanistically, PARP16 interacted with IRE1\u03b1 and ADP-ribosylated IRE1\u03b1 and then mediated the hypertrophic responses through activating the IRE1\u03b1\u2013sXBP1\u2013GATA4 pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Collectively, our results implicated that PARP16 is a contributor to pathological cardiac hypertrophy at least in part via activating the IRE1\u03b1\u2013sXBP1\u2013GATA4 pathway, and may be regarded as a new potential target for exploring effective therapeutic interventions of pathological cardiac hypertrophy and heart failure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00018-023-04805-9","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T12:02:19Z","timestamp":1684843339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1\u03b1\u2013sXBP1\u2013GATA4 pathway"],"prefix":"10.1007","volume":"80","author":[{"given":"Haibi","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4768-2286","authenticated-orcid":false,"given":"Di","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"issue":"21","key":"4805_CR1","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","volume":"141","author":"Z Ren","year":"2020","unstructured":"Ren Z, Yu P, Li D, Li Z, Liao Y, Wang Y et al (2020) Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy. Circulation 141(21):1704\u20131719. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043053","journal-title":"Circulation"},{"key":"4805_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45\u201379. https:\/\/doi.org\/10.1146\/annurev.physiol.65.092101.142243","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"4805_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cmet.2015.01.016","volume":"21","author":"ZV Wang","year":"2015","unstructured":"Wang ZV, Hill JA (2015) Protein quality control and metabolism: bidirectional control in the heart. Cell Metab 21(2):215\u2013226. https:\/\/doi.org\/10.1016\/j.cmet.2015.01.016","journal-title":"Cell Metab"},{"issue":"1","key":"4805_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/CIRCRESAHA.118.313854","volume":"124","author":"EA Blackwood","year":"2019","unstructured":"Blackwood EA, Hofmann C, Santo Domingo M, Bilal AS, Sarakki A, Stauffer W et al (2019) ATF6 regulates cardiac hypertrophy by transcriptional induction of the mTORC1 activator, Rheb. Circ Res 124(1):79\u201393. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313854","journal-title":"Circ Res"},{"issue":"2","key":"4805_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/CIRCRESAHA.121.319745","volume":"130","author":"L Yang","year":"2022","unstructured":"Yang L, Dai R, Wu H, Cai Z, Xie N, Zhang X et al (2022) Unspliced XBP1 counteracts beta-catenin to inhibit vascular calcification. Circ Res 130(2):213\u2013229. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319745","journal-title":"Circ Res"},{"key":"4805_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110022","volume":"125","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chen W, Wang Y (2020) STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress. Biomed Pharmacother 125:110022. https:\/\/doi.org\/10.1016\/j.biopha.2020.110022","journal-title":"Biomed Pharmacother"},{"key":"4805_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12967-015-0725-4","volume":"13","author":"Q Duan","year":"2015","unstructured":"Duan Q, Chen C, Yang L, Li N, Gong W, Li S et al (2015) MicroRNA regulation of unfolded protein response transcription factor XBP1 in the progression of cardiac hypertrophy and heart failure in vivo. J Transl Med 13:363. https:\/\/doi.org\/10.1186\/s12967-015-0725-4","journal-title":"J Transl Med"},{"issue":"11","key":"4805_CR8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/ncb2593","volume":"14","author":"M Jwa","year":"2012","unstructured":"Jwa M, Chang P (2012) PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK- and IRE1alpha-mediated unfolded protein response. Nat Cell Biol 14(11):1223\u20131230. https:\/\/doi.org\/10.1038\/ncb2593","journal-title":"Nat Cell Biol"},{"issue":"2","key":"4805_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chembiol.2021.07.008","volume":"29","author":"V Palve","year":"2022","unstructured":"Palve V, Knezevic CE, Bejan DS, Luo Y, Li X, Novakova S et al (2022) The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors. Cell Chem Biol 29(2):202-214.e7. https:\/\/doi.org\/10.1016\/j.chembiol.2021.07.008","journal-title":"Cell Chem Biol"},{"key":"4805_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2017.34","volume":"3","author":"J Wang","year":"2017","unstructured":"Wang J, Zhu C, Song D, Xia R, Yu W, Dang Y et al (2017) Epigallocatechin-3-gallate enhances ER stress-induced cancer cell apoptosis by directly targeting PARP16 activity. Cell Death Discov 3:17034. https:\/\/doi.org\/10.1038\/cddiscovery.2017.34","journal-title":"Cell Death Discov"},{"issue":"5","key":"4805_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.apsb.2020.12.010","volume":"11","author":"F Long","year":"2021","unstructured":"Long F, Yang D, Wang J, Wang Q, Ni T, Wei G et al (2021) SMYD3-PARP16 axis accelerates unfolded protein response and mediates neointima formation. Acta Pharm Sin B 11(5):1261\u20131273. https:\/\/doi.org\/10.1016\/j.apsb.2020.12.010","journal-title":"Acta Pharm Sin B"},{"issue":"21","key":"4805_CR12","doi-asserted-by":"publisher","first-page":"21423","DOI":"10.18632\/aging.103895","volume":"12","author":"D Yang","year":"2020","unstructured":"Yang D, Wang Q, Wei G, Wu J, Zhu YC, Zhu Q et al (2020) Smyd3-PARP16 axis accelerates unfolded protein response and vascular aging. Aging 12(21):21423\u201321445. https:\/\/doi.org\/10.18632\/aging.103895","journal-title":"Aging"},{"issue":"9","key":"4805_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13212","volume":"19","author":"D Yang","year":"2020","unstructured":"Yang D, Wei G, Long F, Nie H, Tian X, Qu L et al (2020) Histone methyltransferase Smyd3 is a new regulator for vascular senescence. Aging Cell 19(9):e13212. https:\/\/doi.org\/10.1111\/acel.13212","journal-title":"Aging Cell"},{"issue":"5","key":"4805_CR14","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1152\/japplphysiol.01383.2010","volume":"111","author":"IG Lunde","year":"2011","unstructured":"Lunde IG, Kvaloy H, Austbo B, Christensen G, Carlson CR (2011) Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes. J Appl Physiol 111(5):1278\u20131289. https:\/\/doi.org\/10.1152\/japplphysiol.01383.2010","journal-title":"J Appl Physiol"},{"issue":"1","key":"4805_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41467-017-00171-w","volume":"8","author":"Y Yao","year":"2017","unstructured":"Yao Y, Lu Q, Hu Z, Yu Y, Chen Q, Wang QK (2017) A non-canonical pathway regulates ER stress signaling and blocks ER stress-induced apoptosis and heart failure. Nat Commun 8(1):133. https:\/\/doi.org\/10.1038\/s41467-017-00171-w","journal-title":"Nat Commun"},{"issue":"10","key":"4805_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","volume":"92","author":"H Akazawa","year":"2003","unstructured":"Akazawa H, Komuro I (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92(10):1079\u20131088. https:\/\/doi.org\/10.1161\/01.RES.0000072977.86706.23","journal-title":"Circ Res"},{"issue":"6","key":"4805_CR17","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/01.RES.0000215985.18538.c4","volume":"98","author":"T Oka","year":"2006","unstructured":"Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA et al (2006) Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 98(6):837\u2013845. https:\/\/doi.org\/10.1161\/01.RES.0000215985.18538.c4","journal-title":"Circ Res"},{"issue":"39","key":"4805_CR18","doi-asserted-by":"publisher","first-page":"14471","DOI":"10.1073\/pnas.0602543103","volume":"103","author":"E Bisping","year":"2006","unstructured":"Bisping E, Ikeda S, Kong SW, Tarnavski O, Bodyak N, McMullen JR et al (2006) Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci USA 103(39):14471\u201314476. https:\/\/doi.org\/10.1073\/pnas.0602543103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"50","key":"4805_CR19","doi-asserted-by":"publisher","first-page":"38949","DOI":"10.1074\/jbc.R000029200","volume":"275","author":"JD Molkentin","year":"2000","unstructured":"Molkentin JD (2000) The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275(50):38949\u201338952. https:\/\/doi.org\/10.1074\/jbc.R000029200","journal-title":"J Biol Chem"},{"issue":"22","key":"4805_CR20","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.21037\/atm-20-7041","volume":"8","author":"Y Shen","year":"2020","unstructured":"Shen Y, Zhang X, Li C, Wang X, Ye Y, Yuan J et al (2020) Pressure overload promotes cystatin C secretion of cardiomyocytes to regulate the MAPK signaling pathway and mediate cardiac hypertrophy. Ann Transl Med 8(22):1514. https:\/\/doi.org\/10.21037\/atm-20-7041","journal-title":"Ann Transl Med"},{"issue":"2","key":"4805_CR21","doi-asserted-by":"publisher","first-page":"H486","DOI":"10.1152\/ajpheart.00437.2004","volume":"288","author":"JB Pillai","year":"2005","unstructured":"Pillai JB, Russell HM, Raman J, Jeevanandam V, Gupta MP (2005) Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure. Am J Physiol Heart Circ Physiol 288(2):H486\u2013H496. https:\/\/doi.org\/10.1152\/ajpheart.00437.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"4805_CR22","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.bbrc.2012.11.132","volume":"430","author":"YC Biao Geng","year":"2013","unstructured":"Biao Geng YC, Gao S, Lu J, Zhang L, Zou J, Liu M, Yu S, Ye J, Liu P (2013) PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1. Biochem Biophys Res Commun 430(3):944\u2013950. https:\/\/doi.org\/10.1016\/j.bbrc.2012.11.132","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4805_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1210\/me.2013-1265","volume":"28","author":"DJ Sartori","year":"2014","unstructured":"Sartori DJ, Wilbur CJ, Long SY, Rankin MM, Li C, Bradfield JP et al (2014) GATA factors promote ER integrity and beta-cell survival and contribute to type 1 diabetes risk. Mol Endocrinol 28(1):28\u201339. https:\/\/doi.org\/10.1210\/me.2013-1265","journal-title":"Mol Endocrinol"},{"issue":"3","key":"4805_CR24","doi-asserted-by":"publisher","first-page":"C702","DOI":"10.1152\/ajpcell.00173.2007","volume":"294","author":"A Zhang","year":"2008","unstructured":"Zhang A, David JJ, Subramanian SV, Liu X, Fuerst MD, Zhao X et al (2008) Serum response factor neutralizes Pur alpha- and Pur beta-mediated repression of the fetal vascular smooth muscle alpha-actin gene in stressed adult cardiomyocytes. Am J Physiol Cell Physiol 294(3):C702\u2013C714. https:\/\/doi.org\/10.1152\/ajpcell.00173.2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"4805_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1142\/S0192415X18500532","volume":"46","author":"S Sun","year":"2018","unstructured":"Sun S, Li T, Jin L, Piao ZH, Liu B, Ryu Y et al (2018) Dendropanax morbifera prevents cardiomyocyte hypertrophy by inhibiting the Sp1\/GATA4 pathway. Am J Chin Med 46(5):1021\u20131044. https:\/\/doi.org\/10.1142\/S0192415X18500532","journal-title":"Am J Chin Med"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04805-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-04805-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-04805-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T10:22:59Z","timestamp":1686910979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-04805-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4805"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-04805-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"28 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare that they have no confilct of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the experimental procedures involving animals were conformed to the Animal Welfare Act Guide for Use and Care of Laboratory Animals, and were approved by Institutional Animal Care and Use Committee (IACUC), Fudan University, China. All animals were housed under specific pathogen-free (SPF) conditions at a stable temperature of 24\u00a0\u00b0C and fed with chow diet and water at libitum. The male mice were chosen because of the variables (uncertain hormone changes et al<i>.<\/i>) in female mice. The mice were euthanized by intraperitoneal (i.p.) administration of pentobarbital sodium (50\u00a0mg\/kg body weight) then the hearts were harvested for further examination.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement of animal studies"}}],"article-number":"161"}}